First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 53.3% of the 1,013 shares held after it.
No other insider bought within 30 days.
141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Ciaramello Kathleen E bought about $48.9K of JJSF on Nov 20, 2025, the largest insider purchase at the company on our record; 141 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 8, 2024.
The trade is 26.7% of the 789 shares held after it.
2 other insiders sold within 30 days.
141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Human Resources Kehoe Mary Lou sold about $36.0K of JJSF on Nov 22, 2024; 2 other insiders sold within 30 days and 141 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 9, 2024.
The trade is 32.7% of the 963 shares held after it.
2 other insiders sold within 30 days.
141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Senior VP, Operations Cranmer Robert sold about $52.0K of JJSF on Nov 19, 2024; 2 other insiders sold within 30 days and 141 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 15, 2024.
The trade is 0.3% of the 67,636 shares held after it.
2 other insiders sold within 30 days.
141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Roshkoff Marjorie Shreiber sold about $33.8K of JJSF on Nov 15, 2024; 2 other insiders sold within 30 days and 141 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Aug 15, 2024.
The trade is 0.2% of the 67,845 shares held after it.
2 other insiders sold within 30 days.
141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Roshkoff Marjorie Shreiber sold about $23.6K of JJSF on Nov 15, 2024; 2 other insiders sold within 30 days and 141 funds added in the latest 13F quarter.
52 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.5B
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
$1.4B
FY Sep 2021
n/a
Jun 2026
$426.0M
Mar 2026
$344.8M
Dec 2025
$343.8M
Sep 2025
$410.2M
Jun 2025
$454.3M
Jun 2025
$454.3M
Mar 2025
$356.1M
Mar 2025
$356.1M
At each fiscal year end
Single quarter
Net margin, TTM
+3.2%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+3.4%
FY Sep 2021
n/a
Jun 2026
+8.3%
Mar 2026
+0.5%
Dec 2025
+0.3%
Sep 2025
+2.8%
Jun 2025
+9.7%
Jun 2025
n/a
Mar 2025
+1.4%
Mar 2025
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$92.0M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM JJSF
FY Sep 2025
$82.3M
FY Sep 2024
n/a
FY Sep 2023
$67.5M
FY Sep 2022
-$61.2M
FY Sep 2021
n/a
Jun 2026
$30.7M
Mar 2026
-$502.0K
Dec 2025
$17.0M
Sep 2025
$44.8M
Jun 2025
$28.5M
Jun 2025
n/a
Mar 2025
-$7.2M
Mar 2025
n/a
At each fiscal year end
Single quarter
Debt to equity
0.06x
long-term 2026-06-27 plus current 2026-03-28; equity 2026-06-27
Debt to equity JJSF
FY Sep 2025
0.00x
FY Sep 2024
0.00x
FY Sep 2023
0.03x
FY Sep 2022
0.06x
FY Sep 2021
0.00x
Jun 2026
0.06x
Mar 2026
0.03x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Mar 2025
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
2.93x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-03-28
Cash flow to debt JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
6.38x
FY Sep 2022
0.47x
FY Sep 2021
n/a
Jun 2026
2.93x
Mar 2026
5.84x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Mar 2025
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.3%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity JJSF
FY Sep 2025
+6.8%
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+5.5%
FY Sep 2021
+6.7%
Jun 2026
+5.3%
Mar 2026
+6.4%
Dec 2025
+6.6%
Sep 2025
+6.8%
Jun 2025
+8.8%
Jun 2025
+8.2%
Mar 2025
+8.2%
Mar 2025
+9.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.6%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets JJSF
FY Sep 2025
+4.8%
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+4.0%
FY Sep 2021
+5.1%
Jun 2026
+3.6%
Mar 2026
+4.3%
Dec 2025
+4.6%
Sep 2025
+4.8%
Jun 2025
+6.0%
Jun 2025
+5.6%
Mar 2025
+5.6%
Mar 2025
+6.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+5.3%
operating income after a 19.9% effective tax rate, over long-term 2026-06-27 plus current 2026-03-28 plus average of 2025-06-28 and 2026-06-27 minus cash
Return on invested capital JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+6.3%
FY Sep 2021
n/a
Jun 2026
+5.3%
Mar 2026
+6.4%
Dec 2025
+7.0%
Sep 2025
n/a
Jun 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Mar 2025
+8.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.1%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+6.2%
FY Sep 2021
n/a
Jun 2026
+5.1%
Mar 2026
+6.5%
Dec 2025
+6.7%
Sep 2025
n/a
Jun 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Mar 2025
+8.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
32.06x
close 2026-10-23 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
55.53x
FY Sep 2021
52.80x
Jun 2026
29.02x
Mar 2026
26.70x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Jun 2025
28.75x
Mar 2025
33.37x
Mar 2025
29.99x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.6B
market value at close 2026-10-23 on 2026-08-03 shares, plus long-term 2026-06-27 plus current 2026-03-28, minus cash 2026-06-27
Enterprise value JJSF
FY Sep 2025
$1.8B
FY Sep 2024
$3.2B
FY Sep 2023
$3.1B
FY Sep 2022
$2.6B
FY Sep 2021
$2.6B
Jun 2026
$1.4B
Mar 2026
$1.5B
Dec 2025
$1.7B
Sep 2025
$1.8B
Jun 2025
$2.1B
Jun 2025
$2.1B
Mar 2025
$2.5B
Mar 2025
$2.5B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield JJSF
FY Sep 2025
+4.4%
FY Sep 2024
n/a
FY Sep 2023
+2.1%
FY Sep 2022
-2.3%
FY Sep 2021
n/a
Jun 2026
+6.5%
Mar 2026
+5.9%
Dec 2025
+4.8%
Sep 2025
+4.4%
Jun 2025
+3.1%
Jun 2025
+3.8%
Mar 2025
+3.3%
Mar 2025
+3.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
no prior four-quarter EPS window to measure growth
PEG, trailing JJSF
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Mar 2025
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
JJSF ranks highest on financial health (88th percentile) and risk and compliance (51st), and lowest on growth (38th), among Food & Beverage peers.
Profitability
47
Inputs
Return on equity+5.3% · 52 pct, sector of 66
Return on assets+3.6% · 63 pct, sector of 77
Return on invested capital+5.3% · 23 pct, sector of 32
Return on capital employed+5.1% · 49 pct, sector of 62
Financial health
88
Inputs
Debt to equity0.06x · 82 pct, sector of 66
Cash flow to debt2.93x · 95 pct, sector of 59
Growth
38
Inputs
Revenue growth, YoY+0.5% · 38 pct, sector of 89
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
47
Inputs
Funds adding, latest quarter141 · 47 pct, sector of 79
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
51
Inputs
Short interest, % of float+6.4% · 38 pct, sector of 100
Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 58
EPA cases per $1B revenue, 5y0.63 per $1B · 0 pct, sector of 58
New text in Risk Factors, latest 10-K+8.4% · 66 pct, sector of 66
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.